Peder Svensson

1.2k total citations
35 papers, 908 citations indexed

About

Peder Svensson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, Peder Svensson has authored 35 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 7 papers in Spectroscopy. Recurrent topics in Peder Svensson's work include Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Computational Drug Discovery Methods (5 papers). Peder Svensson is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Computational Drug Discovery Methods (5 papers). Peder Svensson collaborates with scholars based in Sweden, Denmark and United Kingdom. Peder Svensson's co-authors include Lena Hartelius, Clas Sonesson, Per Ahlberg, Nicholas Waters, Marcus Malo, Lars Brive, Dieter Cremer, Fredrik Pettersson, Kristina Luthman and Elfi Kraka and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Journal of the American College of Cardiology.

In The Last Decade

Peder Svensson

32 papers receiving 860 citations

Peers

Peder Svensson
Frederick J. Marshall United States
Michael W. Moore United States
Stephen C. Olson United States
William A. Carroll United States
Joel R. Gever United States
Peder Svensson
Citations per year, relative to Peder Svensson Peder Svensson (= 1×) peers Xavier Gironès

Countries citing papers authored by Peder Svensson

Since Specialization
Citations

This map shows the geographic impact of Peder Svensson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peder Svensson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peder Svensson more than expected).

Fields of papers citing papers by Peder Svensson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peder Svensson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peder Svensson. The network helps show where Peder Svensson may publish in the future.

Co-authorship network of co-authors of Peder Svensson

This figure shows the co-authorship network connecting the top 25 collaborators of Peder Svensson. A scholar is included among the top collaborators of Peder Svensson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peder Svensson. Peder Svensson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stan, Tiberiu Loredan, Pär Halje, Azat Nasretdinov, et al.. (2024). Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis. Neurotherapeutics. 21(2). e00334–e00334. 5 indexed citations
2.
Hjorth, Stephan, Nicholas Waters, Joakim Tedroff, et al.. (2020). (3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. Journal of Pharmacology and Experimental Therapeutics. 374(3). 404–419. 4 indexed citations
3.
Waters, Nicholas, Clas Sonesson, Peder Svensson, et al.. (2020). Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics. 374(1). 113–125. 18 indexed citations
4.
Svensson, Peder, et al.. (2017). Oxetane Substrates of Human Microsomal Epoxide Hydrolase. Drug Metabolism and Disposition. 45(8). 966–973. 13 indexed citations
5.
Waters, Nicholas, et al.. (2016). In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery. ACS Chemical Neuroscience. 8(4). 785–797. 11 indexed citations
6.
Nylander, Sven, S. KENNETH PEHRSSON, Tord Inghardt, et al.. (2015). A SPECIFIC ANTIDOTE FOR TICAGRELOR. Journal of the American College of Cardiology. 65(10). A253–A253. 1 indexed citations
8.
Mattsson, Cecilia, et al.. (2013). Structure–activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT6 receptor agonists. European Journal of Medicinal Chemistry. 63. 578–588. 7 indexed citations
9.
Mattsson, C. Mikael, Peder Svensson, & Clas Sonesson. (2013). A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. European Journal of Medicinal Chemistry. 73. 177–186. 24 indexed citations
10.
Pettersson, Fredrik, Peder Svensson, Nicholas Waters, & Clas Sonesson. (2013). Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines. European Journal of Medicinal Chemistry. 62. 241–255. 7 indexed citations
11.
Malo, Marcus, Lars Brive, Kristina Luthman, & Peder Svensson. (2012). Investigation of D2 Receptor–Agonist Interactions Using a Combination of Pharmacophore and Receptor Homology Modeling. ChemMedChem. 7(3). 471–482. 15 indexed citations
12.
Malo, Marcus, Lars Brive, Kristina Luthman, & Peder Svensson. (2012). Investigation of D1 Receptor–Agonist Interactions and D1/D2 Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling. ChemMedChem. 7(3). 483–494. 13 indexed citations
13.
Malo, Marcus, Lars Brive, Kristina Luthman, & Peder Svensson. (2010). Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features. ChemMedChem. 5(2). 232–246. 20 indexed citations
14.
Dyhring, Tino, Elsebet Ø. Nielsen, Clas Sonesson, et al.. (2009). The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties. European Journal of Pharmacology. 628(1-3). 19–26. 61 indexed citations
15.
Nachin, Laurence, et al.. (2008). Heterodimer Formation within Universal Stress Protein Classes Revealed By an In Silico and Experimental Approach. Journal of Molecular Biology. 380(2). 340–350. 18 indexed citations
16.
Rånby, Mats, Sofia Ramström, Peder Svensson, & Tomas Lindahl. (2003). Clotting time by free oscillation rheometry and visual inspection and a viscoelastic description of the clotting phenomenon. Scandinavian Journal of Clinical and Laboratory Investigation. 63(6). 397–406. 35 indexed citations
17.
Oprea, Tudor I., et al.. (2000). Chemical information management in drug discovery: optimizing the computational and combinatorial chemistry interfaces. Journal of Molecular Graphics and Modelling. 18(4-5). 512–524. 42 indexed citations
18.
Oprea, Tudor I., et al.. (2000). Chemical information management in drug discovery: Optimizing the computational and combinatorial chemistry interfaces. Journal of Molecular Graphics and Modelling. 18(4-5). 541–541. 7 indexed citations
19.
Hartelius, Lena & Peder Svensson. (1994). Speech and Swallowing Symptoms Associated with Parkinson’s Disease and Multiple Sclerosis: A Survey. Folia Phoniatrica et Logopaedica. 46(1). 9–17. 313 indexed citations
20.
Cremer, Dieter, Peder Svensson, Elfi Kraka, Zoran Konkoli, & Per Ahlberg. (1993). Exploration of the potential energy surface of C9H9+ by ab initio methods. 2. Is the 1,4-bishomotropylium cation a bishomoaromatic prototype?. Journal of the American Chemical Society. 115(16). 7457–7464. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026